Clinical Trial Update: The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR) [EARLY_Phase 1]

View source ↗

Summary

This early-phase trial update reports preliminary safety and potential efficacy signals for RRG001 after vitrectomy in proliferative diabetic retinopathy and no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• RRG001 (RRG001 gene therapy)

Snippet

Sponsor: Li Xiaorong | Conditions: PDR - Proliferative Diabetic Retinopathy | EARLY_Phase 1 | Status: RECRUITING